PredictLand has developed for a biotech company an application that automates the diagnosis of thousands of PCR tests, drastically reducing analysis times and increasing diagnostic accuracy.
Customer
Our client, with a turnover close to 170 million in 2021, is a biotechnology company specialized in the development and manufacture of in vitro diagnostic products for human applications.
Challenge
You need a solution that allows you to reduce the time and resources spent on PCR test diagnostics, as well as mitigate false positive and false negative diagnostic errors.
Solution
To this end, PredictLand has designed a Machine Learning solution, which automatically interprets the tests and diagnoses the result, achieving accuracies between 97% and 99%, allowing specialists to focus only on critical diagnoses.
The designed solution has been scaled to work with the different devices used in laboratories to perform these diagnostics, and to the catalog of the different tests performed by the biotech company.
This Artificial Intelligence solution displays a visualization of the results and diagnostics for the user.
